Cost-effectiveness of anti-TNFalfa treatment for IBD
Not Applicable
Recruiting
- Conditions
- Inflammatory bowel disease
- Registration Number
- JPRN-UMIN000011358
- Lead Sponsor
- Asahikawa Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 350
Inclusion Criteria
Not provided
Exclusion Criteria
severe heart failure severe kidny disease severe infection severe diabetes severe hypovolemic or nutrirional disorder other severe complications under 16-years-old
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the incremental cost-effectiveness ratio of anti-TNFalfa treatment in IBD patients
- Secondary Outcome Measures
Name Time Method To determine the relationship between disease activity and QOL in IBD patients